Biohaven Ownership | Who Owns Biohaven?
Biohaven Ownership Summary
Biohaven is owned by 3.93% institutional investors, 11.96% insiders, and 84.11% retail investors. Vanguard group is the largest institutional shareholder, holding 8.92% of BHVN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Biohaven shares.
BHVN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Biohaven | 3.93% | 11.96% | 84.11% |
Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 8.41M | 8.92% | $314.27M |
Blackrock funding, inc. /de | 7.67M | 8.12% | $286.37M |
Blackrock | 6.17M | 7.56% | $214.15M |
Janus henderson group | 6.98M | 7.40% | $260.73M |
Stifel financial | 6.56M | 6.95% | $244.99M |
Suvretta capital management | 5.62M | 5.96% | $209.92M |
Farallon capital management | 4.43M | 4.69% | $165.39M |
State street | 3.51M | 3.72% | $131.19M |
Price t rowe associates inc /md/ | 3.41M | 3.62% | $127.45M |
Rp management | 2.94M | 3.11% | $146.74M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rp management | 2.94M | 64.43% | $146.74M |
Oracle investment management | 665.95K | 8.08% | $16.01M |
Suvretta capital management | 5.62M | 7.15% | $209.92M |
5am venture management | 478.97K | 4.27% | $17.89M |
Ars investment partners | 1.04M | 3.50% | $38.87M |
Lion point capital, lp | 22.70K | 3.48% | $545.71K |
Bison wealth | 332.43K | 2.74% | $12.42M |
Boone capital management | 270.20K | 2.21% | $6.50M |
Redmile group | 867.45K | 1.97% | $20.85M |
Stempoint capital lp | 250.56K | 1.92% | $6.02M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Jpmorgan chase | 1.98M | 0.01% | 1.17M |
Norges bank | 902.57K | 0.00% | 902.57K |
Millennium management | 901.26K | 0.01% | 895.46K |
Blackrock funding, inc. /de | 7.67M | 0.01% | 789.83K |
Farallon capital management | 4.43M | 0.84% | 785.58K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perceptive advisors | - | - | -1.49M |
Darwin global management | - | - | -1.48M |
T. rowe price investment management | - | - | -1.23M |
Point72 asset management | - | - | -922.97K |
Adage capital partners gp | 575.00K | 0.04% | -907.49K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 902.57K | 0.00% | 902.57K | $33.71M |
Pfizer | 505.64K | 0.73% | 505.64K | $18.89M |
Emerald advisers | 360.54K | 0.52% | 360.54K | $13.47M |
Artal group | 306.70K | 0.27% | 306.70K | $10.65M |
Emerald mutual fund advisers trust | 226.39K | 0.51% | 226.39K | $8.46M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Allspring global investments | -2.00 |
Principal securities | -3.00 |
Tfc financial management | -3.00 |
Gps wealth strategies group | -5.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 20 | -92.51% | 4,003,493 | -95.66% | 3 | 0.04% | 9 | -94.12% | 7 | -89.23% |
Dec 31, 2024 | 107 | -59.62% | 28,793,137 | -66.29% | 30 | 0.37% | 63 | -53.33% | 20 | -73.68% |
Sep 30, 2024 | 263 | 11.91% | 85,395,678 | 3.25% | 90 | 1.02% | 133 | -5.00% | 76 | 43.40% |
Jun 30, 2024 | 233 | -11.74% | 82,690,329 | 11.42% | 101 | 1.23% | 139 | 6.11% | 51 | -30.14% |
Mar 31, 2024 | 264 | 14.29% | 74,214,259 | 2.75% | 90 | 0.88% | 131 | -2.24% | 73 | 46.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.58M | 2.53% | 35.19K |
Vanguard US Total Market Shares ETF | 2.43M | 2.38% | 217.08K |
iShares Russell 2000 ETF | 2.21M | 2.16% | 1.08K |
BB Biotech AG Ord | 2.04M | 2.02% | - |
Vanguard Small Cap Index | 2.03M | 1.99% | 9.27K |
T. Rowe Price Health Sciences | 1.37M | 1.34% | -410.85K |
SPDR® S&P Biotech ETF | 1.35M | 1.32% | 1.75K |
Vanguard Small Cap Value Index Inv | 1.31M | 1.29% | 4.13K |
Fidelity Select Biotechnology | 1.31M | 1.28% | -23.00K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.31M | 1.28% | 1.72K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $759.65K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $27.65K |
Apr 22, 2024 | CHILDS JOHN W | - | Buy | $3.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | 4 | - |
2024 Q4 | 3 | - |
2024 Q3 | 2 | - |
2024 Q2 | 10 | - |
BHVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools